RGT 8.18% 50.5¢ argent biopharma limited

Dementia, page-3

  1. 683 Posts.
    lightbulb Created with Sketch. 270
    I know it's still a while away, but 'InCann' has been mentioned a few times now:

    'InCann is a bioactive Capsule for symptoms of Crohn's disease and Irritable Bowel Syndrome (IBS). Currently, the latest research and results are based on observational research in Israel and pre-clinical trials on humans in Europe. An official clinical trial program will be initiated in Q2 next year.'

    Another big market to tap into. Here's to hoping.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.